HOME >> MEDICINE >> NEWS
Can we halt the deadly SARS?

AS CONCERN grows over the continuing spread of severe acute respiratory syndrome, or SARS, the key question is whether the disease can be contained. The answer will depend on how the virus spreads and evolves, which is still uncertain, and on whether healthcare systems, particularly in developing countries, can spot SARS and respond effectively.

So far, more than 1900 people in 22 countries have contracted SARS, of whom 63 have died. While China, Hong Kong and Singapore are hardest hit, some experts fear that poor public health monitoring in some countries may mean the number of cases is actually much higher.

The World Health Organization is bracing itself for outbreaks in countries currently claiming to be unaffected by SARS, including Cambodia, Indonesia and the Philippines. "We genuinely believe they have no cases at the moment. But we take the possibility of new outbreaks in this region very seriously," says Peter Cordingley, a spokesman for the WHO's Western Pacific headquarters in Manila.

The disease has so far been detected mainly in countries with good healthcare systems. But David Heymann, head of infectious diseases at the WHO in Geneva, says infected people may well have travelled to a country where an unexplained high fever and cough will not immediately draw attention. But the fact that SARS often infects healthcare workers could give it away, he says.

Even where healthcare facilities are good, it is extremely difficult to monitor an infection with such common symptoms and for which there is not yet a lab test. "With influenza, there is a well-defined test and a worldwide network set up to monitor it- and still there are nasty holes in that network," says Alan Hampson of the WHO Collaborating Centre for Reference and Research on Influenza in Melbourne, Australia.

India could already have undiagnosed cases, he says, as it only started checking airline passengers for SARS on 31 March. "Any country where the healthcare infrastructu
'"/>

Contact: Claire Bowles
claire.bowles@rbi.co.uk
44-207-331-2751
New Scientist
2-Apr-2003


Page: 1 2

Related medicine news :

1. Clot-busting drugs may help detect potentially deadly leg clots
2. Broken heart syndrome: Real, potentially deadly but recovery quick
3. University of Manchester uses crystals to help battle deadly diseases
4. Stanford study reveals that cells linked to asthma and eczema also help cure deadly illness in mice
5. New technology blocks gene to increase immune response against deadly brain tumor cells
6. Protein helps immune system mount instant strike against deadly flu viruses
7. Duke physicians predict risks of deadly infections after cord blood transplants
8. Small and deadly
9. Northwestern Memorial enrolling participants in two trials on new drug to fight deadly cancer
10. Stents combined with clot-busting drugs effective in limiting impact of deadly form of stroke
11. In lab studies, blocking expression of gene reduces invasion of deadly brain tumor cells

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Can halt the deadly SARS

(Date:1/22/2015)... For over 20 years, Dr. David Cruz of Cruz ... has treated just about every type of injury that can result ... those same twenty-plus years, the team at Doctors on Liens ... best possible doctor. With the combined breadth of experience ...
(Date:1/22/2015)... January 22, 2015 Yesterday, Senator ... (D-Concord) and Kristin Olsen (R-Modesto) were honored by ... in advancing biotechnology, biomedical science, medical device and ... each received the “2014 Life Sciences Champion” award ...
(Date:1/22/2015)... DC (PRWEB) January 22, 2015 Payday ... in vulnerable communities and cause financial distress to the ... by analysts at Howard University’s Center on Race and ... dollars in economic activity, payday loans at the same ...
(Date:1/22/2015)... released a new blog post presenting a list of vehicles that ... , Some types of vehicles cannot be covered under an ordinary ... to see if their vehicle qualifies for auto insurance coverage. ... cars that cannot be covered by a plan. Clients have little ...
(Date:12/26/2014)... TX (PRWEB) December 26, 2014 The US ... in this report. In 2013, GlobalData’s forecast estimates that sales ... largest CRC market due to the high incidence of the ... with the 5EU, Japan, and China. Increased sales of CRC ...
Breaking Medicine News(10 mins):Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 3Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 4
(Date:1/23/2015)... DUBLIN , Jan. 23, 2015  Immune Therapeutics, Inc. today ... Inc. for the compounding, packaging and distributing of its naltrexone ... the United States . KRS ... compounding naltrexone tablets in various strengths for individual patients in ...
(Date:1/23/2015)...  HyGreen, Inc., a leader in hand hygiene monitoring, today ... a subsidiary of Ascendis Health Limited, in ... hundreds of millions of patients around the world are ... from patient to patient via the unwashed hands of ...
(Date:1/23/2015)...  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), announced that the number ... lead compound, LB‑100, is being conducted, has been expanded from ... , M.D., the founder and President of Lixte, said that, ... single site. Accrual of patients, however, was slower than projected. ...
Breaking Medicine Technology:Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
Cached News: